Grace E Dean1, Carleara Weiss1, Carla R Jungquist1, Michelle L Klimpt1, Rana Alameri2, Patricia A Ziegler3, Lynn M Steinbrenner3,4, Elisabeth U Dexter4,5, Samjot S Dhillon4,5, Joseph F Lucke6, Suzanne S Dickerson1. 1. School of Nursing, University at Buffalo, State University of New York , Buffalo, New York. 2. Department of Fundamental Nursing, College Nursing, Imam Abdulrahman Bin Faisal University , Dammam, Saudi Arabia. 3. Department of Medicine, VA Western New York Health Systems , Buffalo, New York. 4. Department of Medicine, Jacobs School of Medicine , Buffalo, New York. 5. Thoracic Oncology, Roswell Park Cancer Institute , Buffalo, New York. 6. Department of Psychiatry, Clinical and Research Institute on Addictions , Buffalo, New York.
Abstract
Objective/Background: Insomnia occurs in 50 to 80% of lung cancer survivors. Cognitive behavioral therapy is the standard treatment for insomnia (CBTI); however, treatment length and lack of psychologists trained in CBTI limits access. Brief Behavioral Treatment for Insomnia (BBTI), a nurse-delivered modified CBTI, is proposed. This feasibility pilot study sought to compare the BBTI intervention to attention control Healthy Eating Program (HEP) for insomnia in lung cancer survivors. Participants: The participants comprised adults, 21 years of age or older with insomnia and stage I/II non-small cell lung cancer, more than 6 weeks from surgery and living in Western NY. Methods:Participants (n = 40) were randomly assigned to an experimental (BBTI) or attention control condition (Healthy Eating Program). Thirty participants completed the study. Results:Participants were 66 years of age (± 7.6; range 53-82), 40% (n = 16) male, 87.5% (n = 35) Caucasian, 50% (n = 20) married, BMI 27.7 (± 5.8), and 12% (n = 5) never smokers. Baseline sleep diary sleep efficiency, ISI and other baseline covariates were balanced between the groups. Sleep efficiency improved ≥85% in BBTI group (p = .02), but not in HEP control group (p = 1.00). Mean ISI for BBTI and attention control were 6.40 ± 4.98 and 14.10 ± 4.48 (p = .001) respectively. In addition, BBTI group mean total FACT-L score improved by 6.66 points from baseline while HEP group score worsened (p = .049). Conclusions: BBTI is a practical, evidence-based, clinically relevant intervention that improved sleep and quality of life in lung cancer survivors with insomnia. Additional research to evaluate efficacy, duration, and implementation strategies are essential.
RCT Entities:
Objective/Background: Insomnia occurs in 50 to 80% of lung cancer survivors. Cognitive behavioral therapy is the standard treatment for insomnia (CBTI); however, treatment length and lack of psychologists trained in CBTI limits access. Brief Behavioral Treatment for Insomnia (BBTI), a nurse-delivered modified CBTI, is proposed. This feasibility pilot study sought to compare the BBTI intervention to attention control Healthy Eating Program (HEP) for insomnia in lung cancer survivors. Participants: The participants comprised adults, 21 years of age or older with insomnia and stage I/II non-small cell lung cancer, more than 6 weeks from surgery and living in Western NY. Methods:Participants (n = 40) were randomly assigned to an experimental (BBTI) or attention control condition (Healthy Eating Program). Thirty participants completed the study. Results:Participants were 66 years of age (± 7.6; range 53-82), 40% (n = 16) male, 87.5% (n = 35) Caucasian, 50% (n = 20) married, BMI 27.7 (± 5.8), and 12% (n = 5) never smokers. Baseline sleep diary sleep efficiency, ISI and other baseline covariates were balanced between the groups. Sleep efficiency improved ≥85% in BBTI group (p = .02), but not in HEP control group (p = 1.00). Mean ISI for BBTI and attention control were 6.40 ± 4.98 and 14.10 ± 4.48 (p = .001) respectively. In addition, BBTI group mean total FACT-L score improved by 6.66 points from baseline while HEP group score worsened (p = .049). Conclusions: BBTI is a practical, evidence-based, clinically relevant intervention that improved sleep and quality of life in lung cancer survivors with insomnia. Additional research to evaluate efficacy, duration, and implementation strategies are essential.
Authors: Ilkka K Ilonen; Jari V Räsänen; Aija Knuuttila; Eero I Sihvo; Harri Sintonen; Anssi R A Sovijärvi; Jarmo A Salo Journal: Lung Cancer Date: 2010-04-14 Impact factor: 5.705
Authors: Diana Taibi Buchanan; Susan M McCurry; Kristi Eilers; Shauna Applin; Ellita T Williams; Joachim G Voss Journal: Behav Sleep Med Date: 2016-06-30 Impact factor: 2.964